Glenmark Pharma gets USFDA nod for seizure treatment drug

Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Topiramate extended-release capsules USP in the strengths of 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg, Glenmark said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3czxRNh
via IFTTT